The dumbphone revival has been gathering momentum in recent years, and the newly revived Commodore brand wants in. The computing icon, best known for the machines that defined a generation of 1980s ...
Anna Wintour, l’ex direttrice di Vogue, negli US Open di tennis del 2014 consacrò dalle tribune il ritorno dei cellulari a conchiglia. A distanza di anni l’effetto farfalla ha generato il Commodore ...
Commodore torna sul mercato e lo fa con un prodotto inatteso: non un computer, ma un telefono a conchiglia. Si chiama Callback 8020 ed è un cellulare che punta tutto sull'effetto nostalgia e sul ...
Unabhängig und kostenlos dank Ihres Klicks Die mit einem Symbol gekennzeichneten Links sind Affiliate-Links. Erfolgt darüber ein Einkauf, erhalten wir eine Provision ohne Mehrkosten für Sie. Die ...
The company responsible for the Commodore 64, the best-selling desktop computer model of all time, is back. And Commodore’s latest unveiling feels appropriately retro: a “digital detox” flip phone ...
Commodore présente le Callback 8020, un téléphone à clapet tournant sous Sailfish OS. Vendu à partir de 499 $, il bloque les navigateurs web et les réseaux sociaux pour offrir une alternative aux ...
The recently resurrected Commodore is getting back into phones, but rather than taking on the likes of Apple and Samsung at their own game, the Commodore Callback 8020 is a proudly non-conformant flip ...
Un telefono “stupido” per evitare di diventare “stupidi”. È questa l’idea dietro Callback 8020, un telefono a conchiglia progettato per limitare le distrazioni digitali senza rinunciare completamente ...
Iconic 80s computing pioneer Commodore is launching a surprising new device: it's not a PC, but rather a phone designed to break modern smartphone addiction without leaving users completely stranded.
Function Health, a startup focused on lab testing and body scans for early disease detection, announced Wednesday it has acquired mobile healthcare company Getlabs. Function, which launched in ...
Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results